 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO> 21 CFR Parts 510 and 522</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE> Animal Drugs, Feeds, and Related Products; Euthasol
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=5 f=1 -->
TM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
 Euthanasia Solution</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Food and Drug Administration, HHS.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Final rule.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated
new animal drug application (ANADA) filed by Delmarva Laboratories, Inc. The ANADA provides for intravenous or intracardiac
use of Euthasol
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=5 f=1 -->
TM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
, a generic euthanasia solution containing pentobarbital sodium 390 milligrams per milliliter (mg/mL) and phenytoin
sodium 50 mg/mL, for canine euthanasia. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 March 28, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Larry D. Rollins, Center for Veterinary Medicine (HFV&hyph;110), Food and Drug Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301&hyph;594&hyph;1612.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Delmarva Laboratories, Inc., P.O. Box 525, Midlothian, VA 23113, is sponsor of ANADA 200&hyph;071 which provides
for the use of Euthasol
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=5 f=1 -->
TM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
, a generic euthanasia solution containing pentobarbital sodium 390 mg/mL and phenytoin sodium 50 mg/mL, for intravenous
or intracardiac use for humane, painless, and rapid euthanasia of dogs.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Approval of Delmarva Laboratories' ANADA 200&hyph;071 for Euthasol
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
TM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Euthanasia Solution (pentobarbital sodium 390 mg/mL and phenytoin sodium 50 mg/mL) is as a generic copy of Schering's
NADA 119&hyph;807 for Beuthanasia
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=2 -->
&reg;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
-D Special Solution (pentobarbital sodium 390 mg/mL and phenytoin sodium 50 mg/mL). The ANADA is approved as of February
24, 1994, and the regulations in 21 CFR 522.900 are amended to reflect the approval. The basis for approval is discussed
in the freedom of information summary.
<!-- PJG 0012 frnewline -->
 In accordance with the freedom of information provisions of part 20 (21 CFR part 20) and &sect;514.11(e)(2)(ii) (21
CFR 514.11(e)(2)(ii)), a summary of safety and effectiveness data and information submitted to support approval
of this application may be seen in the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration, rm.
1&hyph;23, 12420 Parklawn Dr., Rockville, MD 20857, from 9 a.m. to 4 p.m., Monday through Friday. 
<!-- PJG 0012 frnewline -->
 In addition, Delmarva Laboratories, Inc., has not been previously listed in 21 CFR 510.600(c)(1) and (c)(2) as sponsor
of an approved application. That section is amended to add entries for the sponsor.
<!-- PJG 0012 frnewline -->
 The agency has carefully considered the potential environmental effects of this action. FDA has concluded that the
action will not have a significant impact on the human environment, and that an environmental impact statement is
not required. The agency's finding of no significant impact and the evidence supporting that finding, contained
in an environmental assessment, may be seen in the Dockets Management Branch (address above) between 9 a.m. and 4 p.m.,
Monday through Friday.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
 21 CFR Part 510
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
 21 CFR Part 522
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Animal drugs.
<!-- PJG 0012 frnewline -->
 Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food
and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 522 are amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
 PART 510_NEW ANIMAL DRUGS
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 1. The authority citation for 21 CFR part 510 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Secs. 201, 301, 501, 502, 503, 512, 701, 721 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 351, 352,
353, 360b, 371, 379e).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 2. Section 510.600 is amended in the table in paragraph (c)(1) by alphabetically adding a new entry for Delmarva Laboratories,
Inc., and in the table in paragraph (c)(2) by numerically adding a new entry ``059079'' to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;510.600 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Names, addresses, and drug labeler codes of sponsors of approved applications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
 * * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (c) *&blank;*&blank;*
<!-- PJG 0012 frnewline -->
 (1) *&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L1,nj,i1,s62,6 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Firm name and address 
<!-- PJG 007 0150 intable -->
1Drug labeler code
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Delmarva Laboratories, Inc., 2200 Wadebridge Rd., P.O. Box 525, Midlothian, VA 23113
<!-- PJG 007 0104 intable -->
059079
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (2) *&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L1,nj,i1,6,r62 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Drug labeler code 
<!-- PJG 007 0150 intable -->
1Firm name and address 
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
059079 
<!-- PJG 007 0104 intable -->
Delmarva Laboratories, Inc., 2200 Wadebridge Rd., P.O. Box 525, Midlothian, VA 23113
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=52 g=1 f=1 -->
 PART 522_IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 3. The authority citation for 21 CFR part 522 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Sec. 512 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;522.900 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 4. Section 522.900 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Euthanasia solution
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is amended in paragraph (b)(2) by removing the phrase ``No. 000061'' and adding in its place ``Nos. 000061 and 059079.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: March 21, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Richard H. Teske,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Center for Veterinary Medicine.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;7202 Filed 3&hyph;25&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
